PREVALENCE OF HFE rs1800562 POLYMORPHISM IN NON-ALCOHOLIC FATTY LIVER DISEASE SUSPICIOUS PATIENTS WITH METABOLIC SYNDROME
Abstract
In recent years, metabolic syndrome has assumed epidemic proportions, affecting large populations around the world. rs1800562 mutant polymorphism of the HFE gene is associated with the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma, and its prevalence in the group of patients with metabolic syndrome living in the Krasnoyarsk Territory has practically not been studied.
It was found that the occurrence of mutant genotypes of the rs1800562 gene polymorphism in the control group significantly differed from global data.
References
Список литературы
Madaleine G., Majumdar A. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation // World Journal of Hepatology. 2020, V. 12, № 12, pp.1168-1181.
Corridani E., et. al. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD // Journal of Hepatology. 2021, V. 75, pp. 506-513.
Ye Q., et. al. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls // PloS One. 2016, V. 11, № 9, pp. e0163423.
Смирнова О. В. и др. Особенности клеточного и гуморального иммунитета у больных острыми нелимфобластным и лимфобластным лейкозами // Сибирский медицинский журнал (Иркутск). 2006. Т. 59, № 1, с. 35-38.
Смирнова О. В., и др. Роль неспецифического иммунитета при прогрессировании миеломной болезни // Современные проблемы науки и образования. 2014. № 2, с. 515.
Смирнова О. В., Манчук В. Т. Особенности клеток иммунной системы при остром лимфобластном лейкозе // Медицинская иммунология. 2013. Т. 15, № 6, с. 577-584.
Смирнова О. В., и др. Роль прооксидантной системы в прогрессировании миеломной болезни // Врач-аспирант. 2013. Т. 60, № 5.1, с. 152-157.
References
Madaleine G., Majumdar A. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation // World Journal of Hepatology. 2020, V. 12, № 12, pp.1168-1181.
Corridani E., et. al. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD // Journal of Hepatology. 2021, V. 75, pp. 506-513.
Ye Q., et. al. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls // PloS One. 2016, V. 11, № 9, pp. e0163423.
Smirnova O. V., et. al. Osobennosti kletochnogo i gumoralnogo immuniteta u bolnuh ostrymi nelimfoblastymi i limfoblastnymi leikozami [The peculiarities of cellular and humoral immunity in patients with acute alymphoblastic and acute lymphoblastic leukemia] // Siberian Medical Journal (Irkutsk). 2006. V. 59, № 1, pp. 35-38.
Smirnova O. V., et. al. Rol’ nespetsificheskogo immuniteta pri progressirovanii mielomnoi bolezni [Role nonspecific immunity in the progression of myeloma disease] // Sovremennye problemy nauki i obrazovaniya. 2014, № 2, pp. 515.
Smirnova O. V., Manchuk V. T. Osobennosti kletok immunnoj sistemy pri ostrom limfoblastnom leikoze [Features of immune cells in acute lymphoblastic leukemia] // Meditsinskaya Immunologiya. 2013. V. 15, № 6, pp. 577-584.
Smirnova O. V., et. al. Rol’ prooksidantnoj sistemy v progressirovanii mielomnoj bolezni [Role of pro-oxidant system in the progression of multiple myeloma disease] // Postgraduate Doctor. 2013. V. 60, № 5.1, pp. 152-157.
Copyright (c) 2023 Darya V. Lagutinskaya, Olga V. Smirnova
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
